Reducing sugars trigger δ-aminolevulinic dehydratase inactivation evidence of in vitro aspirin prevention

The effect of in vitro glycation on δ-aminolevulinic dehydratase (ALA-D) under several experimental conditions was investigated. When preincubated with 500 mM glucose at 37°C for 20 hr, ALA-D was 80% inactivated and glycated hemoglobin levels were increased more than fourfold.Thiobarbituric acid spe...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autor principal: Caballero, F.A
Otros Autores: Gerez, E.N, Polo, C.F, Vazquez, E.S, Del C. Batlle, A.M
Formato: Capítulo de libro
Lenguaje:Inglés
Publicado: 1998
Materias:
Acceso en línea:Registro en Scopus
DOI
Handle
Registro en la Biblioteca Digital
Aporte de:Registro referencial: Solicitar el recurso aquí
LEADER 09063caa a22011057a 4500
001 PAPER-2879
003 AR-BaUEN
005 20230518203221.0
008 190411s1998 xx ||||fo|||| 00| 0 eng|d
024 7 |2 scopus  |a 2-s2.0-0032169737 
024 7 |2 cas  |a Aspirin, 50-78-2; Carbohydrates; Glucose, 50-99-7; Hemoglobin A, Glycosylated; Porphobilinogen Synthase, EC 4.2.1.24 
040 |a Scopus  |b spa  |c AR-BaUEN  |d AR-BaUEN 
030 |a GEPHD 
100 1 |a Caballero, F.A. 
245 1 0 |a Reducing sugars trigger δ-aminolevulinic dehydratase inactivation evidence of in vitro aspirin prevention 
260 |c 1998 
270 1 0 |m Del Batlle A.M.C., A.M.Viamonte 1881 10 A, 1056 Buenos Aires, Argentina; email: cipyp@alad.fcen.uba.ar 
506 |2 openaire  |e Política editorial 
504 |a Batlle, A., Ferramola, A., Grinstein, M., Purification and general properties of δ-aminolevulinate dehydratase from cow liver (1967) Biochem. J., 104, pp. 244-249 
504 |a Beswick, H., Harding, J., Aldehydes and dicarbonyls in nonenzymic glycosylation of proteins (1985) Biochem. J., 226, pp. 385-389 
504 |a Brownlee, M., Glycation products and the pathogenesis of diabetic complications (1992) Diabetes Care, 15, pp. 1835-1843 
504 |a Brownlee, M., Glycation and diabetic complications (1994) Diabetes, 43, pp. 836-841 
504 |a Brownlee, M., The pathological implications of proteins glycation (1995) Clin. Inv. Med., 18, pp. 275-281 
504 |a Caballero, F., Gerez, E., Polo, C., Mompo, O., Vazquez, E., Schultz, R., Bernabó, J., Batlle, A., Estudio sobre las alteraciones en el camino metabólico del hemo en una población de pacientes diabéticos (1995) Medicina, 55, pp. 117-124 
504 |a Cerami, A., Bucala, R., Vlassara, H., A common pathogenic mechanism for diabetic complications (1991) In Diabetic Complications: Epidemiology and Pathogenic Mechanisms, pp. 37-44. , (Edited by Andreani D., Gueriguian J., Striker G. and Conti F.) Raven Press, New York 
504 |a Cherian, M., Abraham, E., In vitro glycation and acetylation (by aspirin) of rat crystallins (1993) Life Sci., 52, pp. 1699-1707 
504 |a Fu, M., Wells-Knecht, K., Blackledge, J., Lyons, T., Thorpe, S., Baynes, J., Glycation, glycoxidation and cross-linking of collagen by glucose: Kinetics, mechanism and inhibition of late stages of the Maillard reaction (1994) Diabetes, 43, pp. 676-683 
504 |a Jain, S., Palmer, N., The effect of oxygen radicals metabolites and vitamin E on glicosylation of proteins (1997) Free Radical Biol. Med., 22, pp. 593-596 
504 |a Kochakian, M., Manjula, B., Egan, J., Chronic dosing with aminoguanidine and novel advanced glycosylation end product-formation inhibitors ameliorates cross-linking of tail tendon collagen in STZ-induced diabetic rats (1996) Diabetes, 45, pp. 1694-1700 
504 |a Nagaraj, R., Shipanova, Y., Faust, F., Protein cross-linking by Maillard reaction: Isolation, characterization and in vivo detection of lysine-lysine cross-link derived from methylglyoxal (1996) J. Biol. Chem., 271, pp. 19338-19345 
504 |a Niehaus, W., Samuelson, B., Formation of malondialdehyde from phospholipid arachidonate during microsomal lipid peroxidation (1968) Eur. J. Biochem., 6, pp. 126-130 
504 |a Parker, M., England, J., Da Costa, J., Hess, R., Goldstein, D., Improved colorimetric assay for glycosylated hemoglobin (1981) Clin. Chem., 27, pp. 669-672 
504 |a Polo, C., Vazquez, E., Gerez, E., Caballero, F., Batlle, A., STZ-induced diabetes in mice and heme pathway enzymes: Effect of allylisopropylacetamide and α-tocopherol (1995) Chem. Biol. Int., 95, pp. 327-334 
504 |a Rendell, M., Nieremberg, J., Brannan, C., Valentine, J., Stephen, P., Dodd, S., Mercer, P., Walder, J., Inhibition of glycation of albumin and hemoglobin by acetylation in vitro and in vivo (1986) Lab. Clin. Med., 108, pp. 286-293 
504 |a Schwartz, J., The role of glycohemoglobin and other proteins in diabetes management (1995) Diabetes Rev., 3, pp. 269-287 
504 |a Strowig, S., Raskin, P., Glycemic control and complications of diabetes: After diabetes control and complications trial (1995) Diabetes Rev., 3, pp. 237-257 
504 |a Swamy, M., Abraham, E., Inhibition of lens crystallin glycation and high molecular weight aggregate formation by aspirin in vitro and in vivo (1989) Invest. Ophthalmol. Vis. Sci., 30, pp. 1120-1126 
504 |a Syrovy, I., Glycation of myofibrillar proteins and ATPase activity after incubation with eleven sugars (1994) Physiol. Res., 43, pp. 61-64 
504 |a Thorpe, S., Baynes, J., Role of the Maillard reaction in diabetes mellitus and diseases of aging (1996) Drugs Aging, 9, pp. 69-77 
504 |a Trüeb, B., Holenstein, C., Fischer, C., Winterhalter, K., Nonenzymatic glycosylation of proteins: A warning (1980) J. Biol. Chem., 255, pp. 6717-6720 
504 |a Wolff, S., Dean, R., Glucose autoxidation and protein modification: The potential role of "autoxidative glycosylation" in diabetes (1987) Biochem. J., 245, pp. 243-250 
504 |a Yim, H., Kang, S., Hah, Y., Chock, P., Yim, M., Free radicals generated during the glycation reaction of amino acids by methylglyoxal (1996) J. Biol. Chem., 270, pp. 28228-28233 
520 3 |a The effect of in vitro glycation on δ-aminolevulinic dehydratase (ALA-D) under several experimental conditions was investigated. When preincubated with 500 mM glucose at 37°C for 20 hr, ALA-D was 80% inactivated and glycated hemoglobin levels were increased more than fourfold.Thiobarbituric acid species were not modified during glycation; therefore ALA-D inactivation cannot be attributed to glucose autoxidation.Acetyl salicylic acid was effective in preventing both hemoglobin glycation and ALA-D inactivation by glucose.A method has been developed for measuring protein glycation in vitro, in a crude preparation of red blood cells, which can also be applied to sugars other than glucose. Copyright (C) 1998 Elsevier Science Inc.  |l eng 
536 |a Detalles de la financiación: Ministerio de Educación y Cultura 
536 |a Detalles de la financiación: National Research Council 
536 |a Detalles de la financiación: Consejo Nacional de Investigaciones Científicas y Técnicas 
536 |a Detalles de la financiación: E. Vazquez and A. M. del C. Batlle are members of the Career of Scientific Researchers at the National Research Council (CONICET). E. Gerez and F. Caballero are Research Assistants at the CONICET. This work was supported by grants from the CONICET. A. M. del C. Batlle thanks the Ministerio de Educación y Ciencia, Spain, for special help. We are most grateful to Mrs. B. Corvalán for technical assistance, and to Mr. M. Buzzi and Mr. Eng V. Di Massi, for buying some chemicals. 
593 |a Ctro. de Invest. sobre P., (CONICET - FCEN, UBA), Ciudad Universitaria, Pabellón II, 1428 Buenos Aires, Argentina 
593 |a Viamonte 1881 10 A, 1056 Buenos Aires, Argentina 
690 1 0 |a Δ-AMINOLEVULINIC DEHYDRATASE 
690 1 0 |a ACETYL SALICYLIC ACID 
690 1 0 |a CARBOHYDRATES 
690 1 0 |a ENZYME INACTIVATION 
690 1 0 |a GLYCATED HEMOGLOBIN 
690 1 0 |a GLYCATION 
690 1 0 |a LIPID PEROXIDATION 
690 1 0 |a ACETYLSALICYLIC ACID 
690 1 0 |a CARBOHYDRATE 
690 1 0 |a GLYCOSYLATED HEMOGLOBIN 
690 1 0 |a PORPHOBILINOGEN SYNTHASE 
690 1 0 |a THIOBARBITURIC ACID 
690 1 0 |a ARTICLE 
690 1 0 |a ENZYME ACTIVITY 
690 1 0 |a ENZYME INACTIVATION 
690 1 0 |a ERYTHROCYTE 
690 1 0 |a HUMAN 
690 1 0 |a HUMAN CELL 
690 1 0 |a LIPID PEROXIDATION 
690 1 0 |a PRIORITY JOURNAL 
690 1 0 |a PROTEIN GLYCOSYLATION 
690 1 0 |a TEMPERATURE 
690 1 0 |a ASPIRIN 
690 1 0 |a CARBOHYDRATE METABOLISM 
690 1 0 |a CARBOHYDRATES 
690 1 0 |a GLUCOSE 
690 1 0 |a GLYCOSYLATION 
690 1 0 |a HEMOGLOBIN A, GLYCOSYLATED 
690 1 0 |a HUMANS 
690 1 0 |a LIPID PEROXIDATION 
690 1 0 |a PORPHOBILINOGEN SYNTHASE 
690 1 0 |a TEMPERATURE 
690 1 0 |a TIME FACTORS 
653 0 0 |a aspirin 
700 1 |a Gerez, E.N. 
700 1 |a Polo, C.F. 
700 1 |a Vazquez, E.S. 
700 1 |a Del C. Batlle, A.M. 
773 0 |d 1998  |g v. 31  |h pp. 441-445  |k n. 3  |p Gen. Pharmacol.  |x 03063623  |w (AR-BaUEN)CENRE-4808  |t General Pharmacology 
856 4 1 |u https://www.scopus.com/inward/record.uri?eid=2-s2.0-0032169737&doi=10.1016%2fS0306-3623%2898%2900016-0&partnerID=40&md5=3a8d61b00b292e24a95bc3dc5f6972b5  |y Registro en Scopus 
856 4 0 |u https://doi.org/10.1016/S0306-3623(98)00016-0  |y DOI 
856 4 0 |u https://hdl.handle.net/20.500.12110/paper_03063623_v31_n3_p441_Caballero  |y Handle 
856 4 0 |u https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_03063623_v31_n3_p441_Caballero  |y Registro en la Biblioteca Digital 
961 |a paper_03063623_v31_n3_p441_Caballero  |b paper  |c PE 
962 |a info:eu-repo/semantics/article  |a info:ar-repo/semantics/artículo  |b info:eu-repo/semantics/publishedVersion 
999 |c 63832